International Journal of Gynecological Cancer

Preface
pp. 1-1(1)
Authors: Poveda, Andres; Vermorken, Jan B

Molecular approaches to management of epithelial ovarian cancer
pp. 2-7(6)
Authors: Bast, R. C.; Yu, Y.; Xu, F. -J.; Le, X. -F.; Mills, G. B.

Staging of early ovarian cancer and the impact of lymph node sampling
pp. 8-11(4)
Author: Trimbos, J. B.

Surgical versus chemical upfront debulking in advanced ovarian cancer
pp. 12-15(4)
Authors: Pecorelli, S.; Favalli, G.

The impact of specialist training for surgery in ovarian cancer
pp. 16-18(3)
Author: Junor, E.

Intravenous chemotherapy for ovarian cancer - the state of the art?
pp. 19-25(7)
Author: Kaye, S. B.

The role of intraperitoneal chemotherapy in epithelial ovarian cancer
pp. 26-32(7)
Author: Vermorken, J. B.

Optimum chemotherapy for ovarian cancer
pp. 33-37(5)
Author: Ozols, R. F.

New cytotoxics and non-cytotoxics in epithelial ovarian cancer
pp. 38-43(6)
Author: Eisenhauer, E. A.

Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy
pp. 44-46(3)
Authors: Epenetos, A. A.; Hird, V.; Lambert, H.; Mason, P.; Coulter, C.

Options for modulation of drug resistance in ovarian cancer
pp. 47-52(6)
Authors: Arts, H. J. G.; Van Der Zee, A. G. J.; De Jong, S.; De Vries, E. G. E.

High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer
pp. 53-56(4)
Author: Ledermann, Jonathan A

Advanced ovarian cancer: update, remarks and conclusions on optimal therapy
pp. 57-60(4)
Author: Poveda, A.